Brnardic, Edward J.
12  Ergebnisse:
Personensuche X
?
1

Recent advances in TRPV4 agonists and antagonists:

Lawhorn, Brian G. ; Brnardic, Edward J. ; Behm, David J.
Bioorganic & Medicinal Chemistry Letters.  30 (2020)  8 - p. 127022 , 2020
 
?
2

Discovery of GSK3527497: A Candidate for the Inhibition of ..:

Brooks, Carl A. ; Barton, Linda S. ; Behm, David J....
Journal of Medicinal Chemistry.  62 (2019)  20 - p. 9270-9280 , 2019
 
?
3

Discovery of Pyrrolidine Sulfonamides as Selective and Oral..:

Brnardic, Edward J. ; Ye, Guosen ; Brooks, Carl...
Journal of Medicinal Chemistry.  61 (2018)  21 - p. 9738-9755 , 2018
 
?
4

Design and Optimization of Sulfone Pyrrolidine Sulfonamide ..:

Pero, Joseph E. ; Matthews, Jay M. ; Behm, David J....
Journal of Medicinal Chemistry.  61 (2018)  24 - p. 11209-11220 , 2018
 
?
 
?
 
?
7

3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive al..:

Brnardic, Edward J. ; Fraley, Mark E. ; Garbaccio, Robert M....
Bioorganic & Medicinal Chemistry Letters.  20 (2010)  10 - p. 3129-3133 , 2010
 
?
9

Optimization of a pyrazoloquinolinone class of Chk1 kinase ..:

Brnardic, Edward J. ; Garbaccio, Robert M. ; Fraley, Mark E....
Bioorganic & Medicinal Chemistry Letters.  17 (2007)  21 - p. 5989-5994 , 2007
 
?
10

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimiz..:

Fraley, Mark E. ; Steen, Justin T. ; Brnardic, Edward J....
Bioorganic & Medicinal Chemistry Letters.  16 (2006)  23 - p. 6049-6053 , 2006
 
?
 
1-12